Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

How Has the Acute Care Syndromic Testing Market Growth Performance Trended Historically, And What Lies Ahead?

In recent years, there has been a significant increase in the size of the acute care syndromic testing market. The market is projected to expand from $4.08 billion in 2024 to $4.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.2%. Key factors that have driven growth in this historical period include heightened awareness of antimicrobial resistance, increased government funding for infectious diseases, greater investment in healthcare infrastructure, a heightened emphasis on syndromic testing, the expansion of telemedicine, and the rise in infectious diseases.

The market for acute care syndromic testing is predicted to experience a surge in size in the upcoming years, shooting up to $7.50 billion by 2029 with a compound annual growth rate (CAGR) of 12.9%. Several factors can explain this growth forecast period like the increasing incidence of infectious diseases, the need for quicker diagnostic solutions, expansion in healthcare services, rising usage of multiplex syndromic panels, and an aging population. Significant emerging trends in the forecast period include a move towards point-of-care testing, the incorporation of cloud-based platforms, the adoption of multiplex panels, the creation of AI-driven tools, and the inclusion of automation in syndromic testing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21078&type=smp

Which Factors and External Forces Are Driving Demand in the Acute Care Syndromic Testing Market?

The rise in infectious disease cases is anticipated to fuel the expansion of the acute care syndromic testing market. Infectious diseases, which can spread between humans, animals, or from the environment, are health conditions triggered by damaging microorganisms such as bacteria, viruses, fungi, or parasites. The escalating occurrence of these diseases is powered by aspects like population expansion, urbanization, international travel, antimicrobial resistance, and changes in climate, thereby augmenting the necessity for efficient prevention and treatment methods. Acute care syndromic testing plays a crucial role in quickly detecting pathogens and co-infections in infectious diseases by utilizing multiplex molecular diagnostics, paving the way for precision-based treatment decisions. For instance, the Health Security Agency reported in Week 4 of February 2024 that the influenza positivity rate had escalated to 16.6%, a rise from the earlier week’s 14.0%. The influenza-like illness (ILI) consultations also surged to 9.8 per 100,000 individuals from the previous week’s 7.5 per 100,000. Furthermore, influenza hospitalizations also saw a significant increase, reaching 7.63 per 100,000 from the preceding week’s 5.12 per 100,000. Consequently, the increasing prevalence of infectious diseases is steering the growth of the acute care syndromic testing market.

Which Segments in the Acute Care Syndromic Testing Offer the Most Growth?

The acute care syndromic testing market covered in this report is segmented –

1) By Disease Type: Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types

2) By Sample Type: Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types

3) By Target: Bacteria, Viruses, Fungi, Parasites

4) By End User: Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users

Subsegments:

1) By Respiratory Diseases: Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases

2) By Gastrointestinal Diseases: Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases

3) By Genitourinary Diseases: Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases

4) By Tropical Diseases: Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases

5) By Other Disease Types: Meningitis, Sepsis, Other Emerging Infectious Diseases

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21078&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Acute Care Syndromic Testing Market?# Market?

North America was the largest region in the acute care syndromic testing market in 2024. The regions covered in the acute care syndromic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theAcute Care Syndromic Testing Market’s Growth?

Top-tier companies working in the acute care syndromic testing market are honing their focus on technological advancements like multiplex real-time polymerase chain reaction (PCR) technology. Their aim is to boost diagnostic accuracy, facilitate quick detection of pathogens, structure lab workflows efficiently, reduce waiting period, and enhance patient results through accurate and on-time treatment strategies. The multiplex real-time PCR technology, an advanced molecular diagnostic approach, can simultaneously detect and measure multiple pathogens or genetic targets within a single PCR reaction thus escalating efficiency and correctness in disease diagnosis. For example, in April 2023, QIAGEN N.V., a biotech research firm based in the Netherlands, introduced the QIAstat-Dx syndromic testing solution in Japan. It includes a SARS-CoV-2 respiratory panel capable of detecting more than 20 pathogens from one single sample. This technology, which uses multiplex real-time PCR, can produce quick results with less labor as compared to individual PCR tests. By the culmination of 2022, there were globally more than 3,500 systems installed that aid in diagnosing conditions relating to the respiratory system, gastrointestinal tract, and meningitis. Available in over 100 nations, it is effectively promoting syndromic testing accessibility worldwide.

View the full report here:

https://www.thebusinessresearchcompany.com/report/acute-care-syndromic-testing-global-market-report

What Are the Key Elements That Define the Acute Care Syndromic Testing Market?

Acute care syndromic testing refers to a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. It is used in emergency and critical care settings to quickly diagnose infectious diseases. This enables faster treatment decisions, improved patient outcomes, and reduced hospital stays.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21078

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model